This is highly relevant considering a novel patient-based study where it was shown that tau burden could play a pivotal role in cognitive impairment in patients with subcortical vascular cognitive impairment (SCVI), suggesting that tau could represent a common pathway for dementia triggered by both cerebrovascular and parenchymal amyloid pathologies [40]. Here, MAPT is linked to Cognitive impairment.